Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
EV3 catheter recall: Firm recalls about 350 TrailBlazer support catheters Nov. 6 after receiving reports from physicians of cracking near the radiopaque marker band during the product's limited initial U.S. release. The malfunction could cause injuries such as insufficient oxygen supply to tissues, damage to blood vessels, heart attack or death, FDA said Jan. 5. The firm says the Class I recall was completed in December and all affected units have been returned to the company. A redesigned TrailBlazer support catheter was launched last month and is available worldwide, ev3 notes
You may also be interested in...
Electronic medical device reporting update
Companies may begin using new FDA device problem codes in their mandatory adverse event reports beginning July 1, the agency says. The new electronic Medical Device Reporting (eMDR) coding 1system revamps the previous system with specific improvements to patient and device problem codes, the inclusion of component codes to clarify the part of the device associated with the adverse event, and improvements to code descriptions and definitions, FDA says. Old MDR codes will still be accepted, but only until April 2, 2010 (2"The Gray Sheet" April 6, 2009)
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.